Analis Expands End to End Next Generation Sequencing Capabilities for Benelux Laboratories with GeneMind Biosciences.
This new exclusive partnership between Analis and GeneMind is built on a shared belief: Advanced molecular technologies, e.g. Next-Generation Sequencing (NGS), should be accessible, reliable, and easy to implement.
GeneMind Biosciences is a fast growing global Next-Generation Sequencer (NGS) manufacturer, providing complete sequencing ecosystem including scalable sequencing platforms, automation-friendly workflows, reagents, consumables, and integrated bioinformatic pipelines.
This collaboration strengthens the Analis NGS portfolio by enabling end-to-end NGS workflows, from nucleic acid extraction and library preparation, to sequencing, bioinformatic analysis, and final report generation.
With GeneMind, we reinforce our position as a single trusted partner for modern genomic technologies across BeNeLux.
Whether you work in clinical diagnostics, public health, research, biotech/biopharma, oncology etc., our partnership with GeneMind is designed to help you work smarter and more efficiently.
Why Choose GeneMind for Next Generation Sequencing in Benelux?
- Clinical and research applications (CE-IVDR & RUO)
- Cost-effective scalable sequencing
- Full workflow, no third-party dependence
- Fast turnaround time (TAT)
- Life-long service & support
Key NGS Applications Supported by GeneMind Sequencing Systems
- Oncology and precision medicine
- Whole-genome and whole-exome sequencing (WGS & WES)
- Infectious disease and microbiology
- Single-cell & spatial transcriptomics
- Reproductive health and NIPT
What Does the Analis and GeneMind Partnership Deliver to Benelux Laboratories?
- Affordable and scalable sequencing
- Local sales & technical support
- Faster response and service
- Direct access to GeneMind innovation
- Strong understanding of regional clinical and research needs